Our in vitro outcomes propose that EAM-2201 ought to be examined regarding opportunity in vivo pharmacokinetic drug–drug interactions caused by time-dependent inhibition of CYP2C8, CYP2C9, CYP2C19 and CYP3A4 routines and aggressive inhibition of UGT1A3 action. Outcome from the novel synthetic cannabinoids AKB48 and 5F-AKB48 on “tetrad”, sensorimotor, neurological and neurochemical https://johnnyz738hwl0.bmswiki.com/user